Calithera Biosciences, Inc.

OTCPK:CALA 株式レポート

時価総額:US$37.0k

Calithera Biosciences マネジメント

マネジメント 基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権n/a
経営陣の平均在職期間データなし
取締役会の平均在任期間8.3yrs

経営陣の近況

Recent updates

Calithera gains 16% as FDA awards Fast Track status for lung cancer candidate

Oct 03

Calithera rises 8% after HC Wainwright upgrades rating to buy

Aug 29

Is Calithera Biosciences (NASDAQ:CALA) In A Good Position To Invest In Growth?

Aug 17
Is Calithera Biosciences (NASDAQ:CALA) In A Good Position To Invest In Growth?

We Think Calithera Biosciences (NASDAQ:CALA) Needs To Drive Business Growth Carefully

Dec 17
We Think Calithera Biosciences (NASDAQ:CALA) Needs To Drive Business Growth Carefully

We Think Calithera Biosciences (NASDAQ:CALA) Needs To Drive Business Growth Carefully

Aug 27
We Think Calithera Biosciences (NASDAQ:CALA) Needs To Drive Business Growth Carefully

The Upcoming Calithera Cystic Fibrosis Data Could Be Significant

Aug 03

Calithera Biosciences Investor Presentation - Slideshow

May 08

Is Calithera Biosciences (NASDAQ:CALA) In A Good Position To Deliver On Growth Plans?

May 02
Is Calithera Biosciences (NASDAQ:CALA) In A Good Position To Deliver On Growth Plans?

What Kind Of Investors Own Most Of Calithera Biosciences, Inc. (NASDAQ:CALA)?

Mar 10
What Kind Of Investors Own Most Of Calithera Biosciences, Inc. (NASDAQ:CALA)?

Calithera Biosciences, Inc. (NASDAQ:CALA) Shares Could Be 46% Below Their Intrinsic Value Estimate

Jan 17
Calithera Biosciences, Inc. (NASDAQ:CALA) Shares Could Be 46% Below Their Intrinsic Value Estimate

Calithera sinks as telaglenastat fails in kidney cancer study; lowers headcount

Jan 04

Companies Like Calithera Biosciences (NASDAQ:CALA) Are In A Position To Invest In Growth

Dec 13
Companies Like Calithera Biosciences (NASDAQ:CALA) Are In A Position To Invest In Growth

Calithera Biosciences Poised For Long-Term Success

Nov 25

Calithera Biosciences (CALA) Investor Presentation - Slideshow

Nov 06

CEO(最高経営責任者

Calithera Biosciences CEOがいない、あるいは彼らに関するデータがない。


取締役

名称ポジション在職期間報酬所有権
Henry Wolff
Independent Director9.9yrsUS$57.95k0%
$ 0
Deepika Pakianathan
Lead Independent Director12.2yrsUS$91.81k0%
$ 0
Sunil Agarwal
Independent Director9.2yrsUS$64.60k0%
$ 0
Scott Garland
Independent Director4.3yrsUS$62.45k0%
$ 0
Susan Jones
Independent Director8.3yrsUS$55.31k0.0074%
$ 2.7
Keith Orford
Director3yrsUS$60.43k0.0011%
$ 0.4
Blake Wise
Independent Director7.2yrsUS$54.45k0%
$ 0

8.3yrs

平均在職期間

55yo

平均年齢

経験豊富なボード: CALAの 取締役会経験豊富 であると考えられます ( 8.3年の平均在任期間)。